Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Can SARS-CoV-2 Virus Use Multiple Receptors to Enter Host Cells?
Laura Kate Gadanec, Kristen Renee McSweeney, Tawar Qaradakhi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 3, pp. 992-992
Open Access | Times Cited: 133

Showing 1-25 of 133 citing articles:

SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19
Evgeni Gusev, Alexey Sarapultsev, Л. В. Соломатина, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1716-1716
Open Access | Times Cited: 214
Protein subunit vaccines: Promising frontiers against COVID-19
Vivek P. Chavda, Eswara Naga Hanuma Kumar Ghali, Pankti C. Balar, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 761-782
Closed Access | Times Cited: 15
Comparative Study of Cytokine Profiles in SARS-CoV-2 Delta and Omicron Variants
Michaela Krivosova, Juliana Hanusrichterová, Vincent Lučanský, et al.
Bratislavské lekárske listy/Bratislava medical journal (2025)
Open Access | Times Cited: 1
Exploiting viral sensing mediated by Toll-like receptors to design innovative vaccines
Rossella Sartorius, Maria Trovato, Roberta Manco, et al.
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 90
Cholesterol-Rich Lipid Rafts as Platforms for SARS-CoV-2 Entry
Selvin Noé Palacios-Rápalo, Luis Adrián De Jesús‐González, Carlos Daniel Cordero‐Rivera, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 88
Toll-Like Receptors as a Therapeutic Target in the Era of Immunotherapies
Mariya Farooq, Maria Batool, Moon Suk Kim, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 68
Neurological complications associated with Covid‐19; molecular mechanisms and therapeutic approaches
Mohammad Mahboubi Mehrabani, Mohammad Sobhan Karvandi, Pedram Maafi, et al.
Reviews in Medical Virology (2022) Vol. 32, Iss. 6
Open Access | Times Cited: 47
Fast-track development of vaccines for SARS-CoV-2: The shots that saved the world
Vivek P. Chavda, Qian Yao, Lalitkumar K. Vora, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 47
Potential Genes Associated with COVID-19 and Comorbidity
Shanshan Feng, Fu-Qiang Song, Wenqiong Guo, et al.
International Journal of Medical Sciences (2022) Vol. 19, Iss. 2, pp. 402-415
Open Access | Times Cited: 37
MicroRNAs and cytokines as potential predictive biomarkers for COVID-19 disease progression
Hatem Mohamed, Aya Eid Abdelkafy, Rasha M. M. Khairy, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 22
Role of Angiotensin II in Cardiovascular Diseases: Introducing Bisartans as a Novel Therapy for Coronavirus 2019
Jordan Swiderski, Laura Kate Gadanec, Vasso Apostolopoulos, et al.
Biomolecules (2023) Vol. 13, Iss. 5, pp. 787-787
Open Access | Times Cited: 21
Mutational dynamics of SARS-CoV-2: Impact on future COVID-19 vaccine strategies
Niloofar Faraji, Tahereh Zeinali, Farahnaz Joukar, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e30208-e30208
Open Access | Times Cited: 11
Precision nutrition to reset virus-induced human metabolic reprogramming and dysregulation (HMRD) in long-COVID
A. Satyanarayan Naidu, Chin‐Kun Wang, Pingfan Rao, et al.
npj Science of Food (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 8
Current Understanding of Multisystem Inflammatory Syndrome (MIS-C) Following COVID-19 and Its Distinction from Kawasaki Disease
Hülya Bükülmez
Current Rheumatology Reports (2021) Vol. 23, Iss. 8
Open Access | Times Cited: 53
A Review of Human Coronaviruses’ Receptors: The Host-Cell Targets for the Crown Bearing Viruses
Aaya Nassar, Ibrahim M. Ibrahim, Fatma G. Amin, et al.
Molecules (2021) Vol. 26, Iss. 21, pp. 6455-6455
Open Access | Times Cited: 53
Inflammatory Mediators of Platelet Activation: Focus on Atherosclerosis and COVID-19
Panagiotis Theofilis, Μarios Sagris, Alexios Antonopoulos, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11170-11170
Open Access | Times Cited: 49
Plasmacytoid Dendritic Cells Depletion and Elevation of IFN-γ Dependent Chemokines CXCL9 and CXCL10 in Children With Multisystem Inflammatory Syndrome
Francesca Caldarale, Mauro Giacomelli, Emirena Garrafa, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 48
Lentil lectin derived from Lens culinaris exhibit broad antiviral activities against SARS-CoV-2 variants
Wenbo Wang, Qianqian Li, Jiajing Wu, et al.
Emerging Microbes & Infections (2021) Vol. 10, Iss. 1, pp. 1519-1529
Open Access | Times Cited: 43
Glutathione deficiency in the pathogenesis of SARS-CoV-2 infection and its effects upon the host immune response in severe COVID-19 disease
Carlos A. Labarrere, Ghassan S. Kassab
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 33
Role of Dipeptidyl Peptidase-4 (DPP4) on COVID-19 Physiopathology
Alba Sebastián-Martín, Belén G. Sánchez, José María Mora-Rodríguez, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 2026-2026
Open Access | Times Cited: 31
DPP-4 Inhibitors as a savior for COVID-19 patients with diabetes
Snehasish Nag, Samanwita Mandal, Oindrila Mukherjee, et al.
Future Virology (2023) Vol. 18, Iss. 5, pp. 321-333
Open Access | Times Cited: 20
Molecular Epidemiology of SARS-CoV-2: The Dominant Role of Arginine in Mutations and Infectivity
Harry Ridgway, Charalampos Ntallis, Christos T. Chasapis, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 309-309
Open Access | Times Cited: 17
Unveiling the Clinical Spectrum of Post-COVID-19 Conditions: Assessment and Recommended Strategies
Abdullah M. Assiri, Tareef Alamaa, Faisal Elenezi, et al.
Cureus (2024)
Open Access | Times Cited: 5
Dissecting the COVID‐19 Immune Response: Unraveling the Pathways of Innate Sensing and Response to SARS‐CoV‐2 Structural Proteins
María Guadalupe Vizoso-Pinto, Leonardo de Paula Pereira, Ana Luiza Pessoa de Mendonça Angelo, et al.
Journal of Molecular Recognition (2025) Vol. 38, Iss. 2
Closed Access
Proinflammatory Cytokines in Chronic Respiratory Diseases and Their Management
Vivek P. Chavda, Rajashri Bezbaruah, Nasima Ahmed, et al.
Cells (2025) Vol. 14, Iss. 6, pp. 400-400
Open Access
Page 1 - Next Page

Scroll to top